Purpose—Much has transpired since the last scientific statement on pediatric stroke was
published 10 years ago. Although stroke has long been recognized as an adult health …

Purpose—The purpose of this statement is to review the literature on childhood stroke and to
provide recommendations for optimal diagnosis and treatment. This statement is intended …

Background Neonates and children differ from adults in physiology, pharmacologic
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …

Background Cerebral sinovenous thrombosis in children is a serious disorder, and
information is needed about its prevention and treatment. Methods The Canadian Pediatric …

Ischemic stroke during infancy and childhood has the potential for life-long morbidity.
Information on the neurologic outcome of children who survive ischemic stroke is lacking …

This chapter about antithrombotic therapy in neonates and children is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Neuroimaging and management advances require review of indications for excluding
cerebral venous sinus (sinovenous) thrombosis (CSVT) in children. Our goals were to …

Stroke is relatively rare in children, but can lead to significant morbidity and mortality.
Understanding that children with strokes present differently than adults and often present …

Cerebral venous sinus (sinovenous) thrombosis (CSVT) is an increasingly recognized
cause of childhood and neonatal stroke. Recent developments in the field highlight the …

This article about antithrombotic therapy in children is part of the 7th American College of
Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …